Patents by Inventor Martin MacPhee

Martin MacPhee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150289861
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques.
    Type: Application
    Filed: March 12, 2015
    Publication date: October 15, 2015
    Inventors: Martin MacPhee, Dawson Beall, Jennifer Brichetti, Belinda Wilmer
  • Publication number: 20150283288
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.
    Type: Application
    Filed: June 22, 2015
    Publication date: October 8, 2015
    Applicant: STB, LTD.
    Inventors: Martin MACPHEE, Dawson BEALL
  • Patent number: 9131929
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Grant
    Filed: April 5, 2011
    Date of Patent: September 15, 2015
    Assignee: STB, Ltd.
    Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
  • Publication number: 20150132363
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm2 of the wound facing surface of the dressing and 13.0 mg/cm2 of the wound facing surface of the dressing. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: January 18, 2015
    Publication date: May 14, 2015
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20150118284
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: December 24, 2014
    Publication date: April 30, 2015
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20130287837
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 31, 2013
    Inventors: Martin MacPhee, Dawson Beall
  • Patent number: 8445009
    Abstract: Disclosed are processes for preparing solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen and liquid compositions useful for preparing the haemostatic layer(s) of these dressings or for treating wounded tissue in a mammal.
    Type: Grant
    Filed: August 6, 2007
    Date of Patent: May 21, 2013
    Assignee: STB, Ltd
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20120321692
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Application
    Filed: February 7, 2012
    Publication date: December 20, 2012
    Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
  • Publication number: 20120148659
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.
    Type: Application
    Filed: February 2, 2012
    Publication date: June 14, 2012
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20120148658
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm2 of the wound facing surface of the dressing and 13.0 mg/cm2 of the wound facing surface of the dressing. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: February 1, 2012
    Publication date: June 14, 2012
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20120150087
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: February 2, 2012
    Publication date: June 14, 2012
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20110196421
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Application
    Filed: April 5, 2011
    Publication date: August 11, 2011
    Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
  • Publication number: 20090075891
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Application
    Filed: August 6, 2008
    Publication date: March 19, 2009
    Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
  • Publication number: 20080080998
    Abstract: Methods are disclosed for sterilizing tissue to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing one or more tissues with irradiation.
    Type: Application
    Filed: July 16, 2007
    Publication date: April 3, 2008
    Inventors: Wilson Burgess, William Drohan, Martin MacPhee, David Mann
  • Publication number: 20080031934
    Abstract: Disclosed are processes for preparing solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen and liquid compositions useful for preparing the haemostatic layer(s) of these dressings or for treating wounded tissue in a mammal.
    Type: Application
    Filed: August 6, 2007
    Publication date: February 7, 2008
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20080033333
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: August 6, 2007
    Publication date: February 7, 2008
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20080033332
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm2 of the wound facing surface of the dressing and 13.0 mg/cm2 of the wound facing surface of the dressing. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: August 6, 2007
    Publication date: February 7, 2008
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20080033331
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.
    Type: Application
    Filed: August 6, 2007
    Publication date: February 7, 2008
    Inventors: Martin MacPhee, Dawson Beall
  • Publication number: 20060182652
    Abstract: Methods are disclosed for sterilizing biological materials to reduce the level of active biological contaminants or pathogens such as viruses, bacteria, nanobacteria, yeasts, molds, mycoplasmas, ureaplasmas, prions and parasites. These methods involve the use of dipeptide stabilizers in methods of sterilizing biological materials with irradiation.
    Type: Application
    Filed: April 7, 2006
    Publication date: August 17, 2006
    Inventors: Wilson Burgess, William Drohan, Martin MacPhee, David Mann, Ewa Maddox
  • Publication number: 20060155234
    Abstract: The present invention relates to a hemostatic dressing which comprises a plurality of layers that contain resorbable materials and/or coagulation proteins. In particular, the invention includes dressings in which a layer of thrombin is sandwiched between a first and second layer of fibrinogen and wherein the layer of thrombin is not coextensive with the first and/or second layer of fibrinogen. The hemostatic dressings are useful for the treatment of wounded tissue.
    Type: Application
    Filed: September 9, 2003
    Publication date: July 13, 2006
    Applicant: American National Red Cross
    Inventors: Martin Macphee, Dawson Beall, Stanley Friedman